Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001209191-24-002928

Chief Medical Officer acquired 26,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Adler Eric Chief Medical Officer 2024-02-02 Grant or award +26,875 26,875 D
Derivatives
Adler Eric Chief Medical Officer 2024-02-02 Grant or award · Employee Stock Option (right to buy) +161,250 161,250 D
Loading xslF345X05/doc4.xml…